Abstract:Purpose: Inactivation of p16 gene by CpG methylation is a frequent event in oral epithelial dysplasia. To investigate the predictive value of p16 methylation on malignant potential in oral epithelial dysplasia, we carried out the prospective cohort study. Experimental Design: One hundred one patients with histologically confirmed mild or moderate oral epithelial dysplasia were included in the present cohort study. p16 Methylation status of the oral epithelial dysplasia lesions from 93 cases was obtained by methylation-specific PCR. Progression of the oral epithelial dysplasia lesions was examined in 78 cases histologically during a 45.8 months follow-up period. The association between p16 methylation and progression of oral epithelial dysplasia was analyzed. Results: Of the 93 enrolled cases, 15 cases were lost during the follow-up because of changes of contact information, with a compliance of 83.9%. p16 Methylation was detectable in oral epithelial dysplasia lesions from 32 (41.0%) of 78 enrolled patients. Oral epithelial dysplasia-related squamous cell carcinomas were observed in 22 patients (28.2%) during the follow-up. Rate of progression to oral cancer in patients with the p16-methylated oral epithelial dysplasia was significantly higher than that with the p16-unmethylated oral epithelial dysplasia (43.8% versus 17.4%; adjusted odds ratio, 3.7; P = 0.013), especially for patients at the baseline age of 60 years (adjusted odds ratio, 12.0; P = 0.003) and patients with moderate oral epithelial dysplasia (adjusted odds ratio, 15.6; P = 0.022). The overall sensitivity and specificity of prediction of malignant transformation of oral epithelial dysplasia by p16 methylation were 63.6% and 67.9%, respectively. Conclusion: p16 Methylation was correlated with malignant transformation of oral epithelial dysplasia and is a potential biomarker for prediction of prognosis of mild or moderate oral epithelial dysplasia. (Clin Cancer Res 2009;15(16):5178-83)

Expression and Methylation of P16 in Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland

Aberrant Protein Expression and Promoter Methylation of P16 Gene Are Correlated with Malignant Transformation of Salivary Pleomorphic Adenoma

Abnormalities of Tumor Suppressor Genes P16 and P15 in Primary Maxillofacial Squamous Cell Carcinomas

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

Promoter Hypermethylation May Contribute to E‑cadherin Repression in the Human Salivary Carcinoma Ex Pleomorphic Adenoma

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR

[The P16 Methylation in Oral Leukoplakia and Oral Squamous Cell Carcinoma].

Quantitative study on expression of p16 multiple tumor suppressor gene in salivary gland neoplasm

Abstract #1339: Methylation of P16 CpG Island Associated with Malignant Transformation of Oral Epithelial Dysplasia: a Prospective Cohort Study

Methylation and expression of p16INK4a gene in laryngeal squamous cell carcinomas

Methylation of E-cadherin, p16, RASSF1A, DAPK and MGMT in salivary gland tissues

Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.

The expression and clinical significance of cyclin D1, p16 in PA and CPA

Methylation Status of P16 Gene in Colorectal Carcinoma and Normal Colonic Mucosa.

Methylation and Aberrant Expression of the p16 Gene in Cervical Carcinoma

Aberrant Methylation in CpG Islands of P15 and P16 Tumor Suppressor Genes in Pancreatic Cancer Tissue

Detection of p16 gene deletion and methylation in esophageal squamous cell carcinoma tissue

EXPRESSION OF P16 GENE IN ORAL SQUAMOUS CELL CARCINOMA AND ITS CLINICOPATHOLOGICAL SIGNIFICANCE

Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics

Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands.